Archives
-
Expandable Shape-Memory Hemostat for Hemorrhage
2026-09-28
The 2026 Advanced Science study reports an expandable nanocomposite-coated shape-memory foam designed for noncompressible hemorrhage, where conventional compression-based materials are difficult to deploy. The device combined rapid volume recovery with blood-cell adhesion and produced faster clotting, lower blood loss, and acceptable preliminary biocompatibility in the reported experimental models.
-
IMP and RNA Modification Mapping: A Practical Guide
2026-09-28
IMP is a nucleotide, not an RNA modification, and that distinction matters when interpreting spatial RNA-modification data. This guide explains how IMP relates to APEX-RNA-MS, what the method reveals about cellular condensates, and how to avoid confusing nucleotide measurements with modified-RNA readouts.
-
HACC-TNF-α-VLPs Boost FMDV Cross-Presentation
2026-09-27
A HACC-TNF-α-VLP nanoparticle system promoted dendritic-cell maturation and HSP90-associated antigen cross-presentation, with increased CD8+ T-cell and mucosal immune responses in mice. The findings point to a vaccine-delivery strategy for addressing cellular-immunity gaps in FMDV-VLP vaccines, while leaving dose, route-comparison, and protection questions for further study.
-
c-Myc Peptide: Assay Workflows and Troubleshooting
2026-09-26
Use c-Myc tag Peptide to test antibody specificity or competitively release c-Myc-tagged fusion proteins in immunoassay workflows. Practical, clearly labeled starting conditions help researchers optimize competition without mistaking this assay reagent for a cellular regulator of IRF3 or c-Myc biology.
-
RNA G-Quadruplexes Shape TDP-43 Condensation and Toxicity
2026-09-25
Oldani et al. report that G-quadruplexes modulate TDP-43 aggregation, condensation, and toxicity across in vitro and cellular models, with outcomes depending on the experimental context. The findings position RNA G-quadruplexes as potential regulators of TDP-43 behavior, while leaving open whether DNA-G-quadruplex stabilizers can be applied to RNA-centered neurobiology experiments.
-
ATP Solution in p21 mRNA Workflows
2026-09-25
See how a high-purity ATP stock can support the in vitro transcription and enzyme-assay steps used to develop mRNA-based research workflows. Practical handling guidance connects ATP-dependent bench work to a bladder-cancer p21 mRNA-LNP study—without confusing a laboratory reagent with a therapeutic ingredient.
-
hCG Represses Decidual CXCL10 via H3K27me3
2026-09-24
This study shows that human chorionic gonadotropin (hCG) can suppress CXCL10 in human decidual stromal cells by promoting EZH2-associated H3K27me3 at a defined CXCL10 promoter region. The findings connect placental signaling to local CD8-cell recruitment and suggest locus-specific chromatin regulation as a mechanism for shaping maternal immune conditions.
-
Exo1: Mechanism, Evidence, and Research Use
2026-09-24
Exo1, or methyl 2-(4-fluorobenzamido)benzoate, is a chemical tool for acute study of exocytic membrane traffic. Product information describes rapid Golgi collapse toward the ER and an approximate exocytosis IC50 of 20 μM, while the available evidence does not establish Exo1 as a tumor extracellular-vesicle therapy.
-
AMD-070 Hydrochloride in CXCR4 Assays
2026-09-23
Use AMD-070 hydrochloride to probe CXCR4-dependent signaling and migration, with assay controls that separate receptor antagonism from toxicity or vehicle effects. A pressure-injury study offers useful lessons in endpoint selection—but its sulfaphenazole findings do not establish a wound-healing effect for mavorixafor.
-
p21 mRNA Delivery with EZ Cap™ Reagent GG
2026-09-23
A practical workflow for using EZ Cap™ Reagent GG in capped p21 mRNA production, quality control, and lipid nanoparticle screening. The approach connects IVT optimization with localized bladder cancer delivery while separating literature findings from conditions that require laboratory validation.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-09-22
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris can invade, proliferate within, and damage insect cells. Pharmacological and cytoskeletal perturbation experiments linked bacterial entry to clathrin-mediated endocytosis, macropinocytosis, microtubules, and actin filaments, while providing a useful framework for mechanistic endocytosis research.
-
GSK J4 HCl: JMJD3 Inhibitor Workflow Guide
2026-09-22
Build reproducible chromatin and inflammatory assays with GSK J4 HCl, a cell-permeable JMJD3 inhibitor designed to release active GSK J1 intracellularly. This guide connects macrophage cytokine workflows with promoter-level H3K27me3 studies and highlights practical controls for inflammation, cancer, and epigenetic regulation research.
-
Thermal-Protective Hydrogel for Curative Tumor Ablation
2026-09-21
The reference study introduces MR@CaP@HA, an injectable hydrogel that combines local thermal insulation with pH/GSH-responsive delivery of mitoxantrone and Resiquimod (R-848) during radiofrequency ablation. By addressing collateral heat injury and weak post-ablation immunity in one platform, the system improved macrophage polarization, dendritic-cell activation, residual-tumor control, and complete tumor eradication in a subset of animals.
-
Exo1: A Trafficking-Centered Assay Strategy
2026-09-21
Exo1 enables mechanistically resolved membrane trafficking inhibition by rapidly reorganizing Golgi–ER traffic and releasing ARF1 from Golgi membranes. This article explains how to use methyl 2-(4-fluorobenzamido)benzoate to interpret exocytosis assays and investigate tumor extracellular vesicle biology without overstating translational evidence.
-
GSK J4 HCl: Translational Control of H3K27
2026-09-20
GSK J4 HCl offers translational researchers a practical way to interrogate JMJD3-driven chromatin remodeling across inflammation, decidual biology, and K27M glioma models. This article connects the compound’s intracellular activation and response benchmarks with the H3K27me3–CXCL10 axis described in human decidua, while defining the controls needed to separate mechanistic insight from pharmacologic overinterpretation.